Skip to main content

Advertisement

SpringerLink
Log in

Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Progressive multifocal leukoencephalopathy is a demyelinating disease with a high mortality caused by the JC virus and occurs in about 5% of HIV-infected patients. Highly active anti-retroviral therapy (HAART) has a proven efficacy in prolonging the survival of patients with AIDS-associated PML, but there are differing opinions about adding cidofovir to the treatment of PML. To investigate the benefit of HAART combined with cidofovir, we retrospectively analysed the survival of 33 patients with AIDS-associated PML proven by PCR in CSF, biopsy or at autopsy. Additionally, we also analysed 37 patients with probable PML. Seventeen (51.5%) of the patients with confirmed PML were treated with HAART and 14 (42.4%) with cidofovir in any combination. Of these patients, 13 (39.4%) were treated with HAART and cidofovir in combination, four (12.1%) patients received only HAART without cidofovir and one (3%) patient received only cidofovir without HAART. Fifteen patients did not receive HAART or cidofovir. The cumulative survival was significantly longer in patients with HAART than in patients without HAART (p = 0.006), independent whether cidofovir was given or not. In comparison with single therapy with HAART, the combination of HAART and cidofovir showed no significant increase in survival (p = 0.435). Therefore, a benefit for cidofovir in addition to HAART in the treatment of PML in HIV-infected patients could not be proven.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andrei G, Snoeck R, Vandeputte M, De Clercq E (1997) Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 41:587–593

    PubMed  CAS  Google Scholar 

  2. Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono MI, Fibbia GC, Mena M, Finazzi MG, Guaraldi G, Ammassari A, d'Arminio Monforte A, Cinque P, De Luca A, for the Italian Registry Investigative Neuro AIDS (IRINA) Study Group (2003) Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 9 (Suppl 1):47–53

    Article  PubMed  CAS  Google Scholar 

  3. Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia-Etxaburu J, Domingo P, Márquez M, Rodriguez- Arrondo FJ, Laguna F, Rubio R, Rodrigo JL, Mallolas J, de Miguel V, and the GESIDA 11/99 Study Group (2003) Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 36:1047–1052

    Article  PubMed  CAS  Google Scholar 

  4. Berger JR (2000) Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2:361–368

    Article  PubMed  Google Scholar 

  5. Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero P, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIVassociated progressive multifocal leukoencephalopathy. Neurology 52:623–625

    PubMed  CAS  Google Scholar 

  6. De Clercq E (2003) Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 16:569–596

    Article  PubMed  CAS  Google Scholar 

  7. De Clercq E (2004) Antiviral drugs in current clinical use. J Clin Virol 30:115–133

    Article  PubMed  CAS  Google Scholar 

  8. De Luca A, Fantoni M, Tartaglione T, Antinori A (1999) Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 52:891–892

    PubMed  CAS  Google Scholar 

  9. De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG, Govoni A, Murri R, Testa L, d'Arminio Monforte A, Antinori A (2000) Cidofovir added to HAART improves virological and clinical outcome in AIDSassociated progressive multifocal leukoencephalopathy. AIDS 14:F117–F121

    Article  PubMed  CAS  Google Scholar 

  10. De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, d'Arminio Monforte A, Antinori A (2001) Potent anti-retroviral therapy with or without cidofovir for AIDSassociated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J Neuro Virol 7:364–368

    CAS  Google Scholar 

  11. Dörries K, Arendt G, Eggers C, RoggendorfW, Dörries R (1998) Nucleic acid detection as a diagnostic tool in polyomavirus JC induced progressive multifocal leukoencephalopathy. J Med Virol 54:196–203

    Article  PubMed  Google Scholar 

  12. Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, Taoufik Y (2001) Cidofovir in AIDSassociated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring. J Neuro Virol 7:375–381

    CAS  Google Scholar 

  13. Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999) Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J NeuroVirol 5:421–429

    Article  PubMed  CAS  Google Scholar 

  14. Happe S, Besselmann M, Matheja P, Rickert CH, Schuierer G, Reichelt D, Husstedt IW (1999) Cidofovir (Vistide) in der Therapie der Progressiven Multifokalen Leukoenzephalopathie (PML) bei AIDS. Nervenarzt 70:935–943

    Article  PubMed  CAS  Google Scholar 

  15. Happe S, Lünenborg N, Rickert CH, Heese C, Reichelt D, Schuierer G, Schul C, Husstedt IW (2000) Progressive multifokale Leukoenzephalopathie im Verlauf der AIDS-Erkrankung. Übersicht und retrospektive Analyse von 17 Patienten. Nervenarzt 71:96–104

    Article  PubMed  CAS  Google Scholar 

  16. Henson J, Rosenblum M, Armstrong D, Furneaux H (1991) Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Neurology 41:1967–1971

    PubMed  CAS  Google Scholar 

  17. Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4:451–456

    Article  PubMed  CAS  Google Scholar 

  18. Koralnik IJ (2004) New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 17:365–370

    Article  PubMed  Google Scholar 

  19. Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Post MJD, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S, and the Adult AIDS Clinical Trials Group 363 Team (2002) A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16:1791–1797

    Article  PubMed  CAS  Google Scholar 

  20. Meylan PRA, Vuadens P, Maeder P, Sahli R, Tagan MC (1999) Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF. Eur Neurol 41:172–174

    Article  PubMed  CAS  Google Scholar 

  21. Moret H, Guichard M, Matheron S, Katlama C, Sazdovitch V, Huraux JM, Ingrand D (1993) Virological diagnosis of progressive multifocal leukoencephalopathy: Detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 31:3310–3313

    PubMed  CAS  Google Scholar 

  22. Razonable RR, Aksamit AJ, Wright AJ, Wilson JW (2001) Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 76:1171–1175

    PubMed  CAS  Google Scholar 

  23. Reilmann R, Imai T, Ringelstein EB, Gaubitz M, Niederstadt TU, Paulus W, Husstedt IW (2005) Remission of progressive multifocal leukoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. J Neurol Neurosurg Psychiatry 76:1304–1305

    Article  PubMed  CAS  Google Scholar 

  24. Roberts MTM, Carmichael A, Lever AML (2003) Prolonged survival in AIDS-related progressive multifocal leukoencephalopathy following antiretroviral therapy and cidofovir. Int J Antimicrob Agents 21:347–349

    Article  PubMed  CAS  Google Scholar 

  25. Segarra-Newnham M, Vodolo KM (2001) Use of cidofovir in progressive multifocal leukoencephalopathy. Ann Pharmacother 35:741–744

    Article  PubMed  CAS  Google Scholar 

  26. Skiest DJ (2002) Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 34:103–115

    Article  PubMed  Google Scholar 

  27. Snoeck R, De Clercq E (2002) Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Curr Opin Investig Drugs 3:1561–1566

    PubMed  CAS  Google Scholar 

  28. Wasmuth JC, Wasmuth-Pietzich A, Spengler U, Rockstroh J (1998) Die progressive multifokale Leukoenzephalopathie. Med Klin 94:264–273

    Article  Google Scholar 

  29. Weber F, Lüke W, Weber T (2004) Die progressive multifokale Leukoenzephalopathie (PML) – Diagnose, Pathogenese und Therapieoptionen. Akt Neurol 31:19–26

    Article  Google Scholar 

  30. Wyen C, Hoffmann C, Schmeißer N, Wöhrmann A, Qurishi N, Rockstroh J, Esser S, Rieke A, Ross B, Lorenzen T, Schmitz K, Stenzel W, Salzberger B, Fätkenheuer G (2004) Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy. Survival and risk factors of death. J Acquir Immune Defic Syndr 37:1263–1268

    Article  PubMed  CAS  Google Scholar 

  31. Zimmermann T, Stingele K, Hartmann M, Haas J, von Einsiedel R, Wildemann B (2001) Successful treatment of AIDS related PML with HAART and cidofovir. Eur J Med Res 6:190–192

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, University of Münster, Albert-Schweitzer-Str. 33, 48149, Münster, Germany

    C. Kraemer MD, S. Evers MD, PhD & I. W. Husstedt MD

  2. Dept. of Neurology, Heinrich Heine University, Düsseldorf, Germany

    T. Nolting MD & G. Arendt MD

Authors
  1. C. Kraemer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Evers MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Nolting MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Arendt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. W. Husstedt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Kraemer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kraemer, C., Evers, S., Nolting, T. et al. Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. J Neurol 255, 526–531 (2008). https://doi.org/10.1007/s00415-008-0731-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0731-z

Key words

Search

Navigation